BLOUNT STRATEGIC INITIATIVES

Lobbying for MYRIAD GENETICS, INC. · Myriad is a genetic testing and precision medicine company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $10,000.00 income · posted Apr 9, 2026

Lobbying activity 1

Veterans

Issues relating to veterans' depression and the Genesight product.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.